SCHEMBL4058745

SCHEMBL4058745

CC(C)(C)OC(=O)Oc1ccc2cc(Br)ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 3/20 0.58
ELANE P08246 1/20 0.54
LMNA P02545 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
MAPT P10636 3/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
ATM Q13315 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
CA2 P00918 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
KDM1A O60341 1/20 0.41
FLT3 P36888 1/20 0.40
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CYP2A6 P11509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4061539 0.90 ELANE (0.65) NCEH1ELANELMNAL3MBTL1MAPT
SCHEMBL4065322 0.84 ELANE (0.68) NCEH1ELANELMNAMAPTNPC1
SCHEMBL4055008 0.83 ELANE (0.57) ELANEL3MBTL1MAPTNPC1TDP1
SCHEMBL933920 0.82 ELANE (0.46) NCEH1ELANELMNAL3MBTL1CA2
SCHEMBL3985477 0.80 ELANE (0.62) ELANELMNAMAPTNPC1RAB9A
SCHEMBL9341912 0.79 ELANE (0.57) ELANELMNAMAPTNPC1RAB9A
SCHEMBL4061370 0.78 ELANE (0.81) ELANELMNAL3MBTL1MAPTRAB9A
SCHEMBL13845254 0.78 ELANE (0.51) NCEH1ELANELMNAL3MBTL1MAPT
SCHEMBL4610370 0.78 NCEH1 (0.67) NCEH1LMNAL3MBTL1MAPTNPC1
SCHEMBL29624638 0.78 NCEH1 (0.67) NCEH1LMNAL3MBTL1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM NCEH1 1736/4885ELANE 422/4885LMNA 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.